Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., was awarded the MANDRAKE 3.0 Indefinite Delivery, Indefinite Quantity (IDIQ) contract by the Department of State Bureau of Medical Services on September 30, 2023, with a five-year performance period through September 29, 2025, and a ceiling value of $100 million. This single-award contract, which requires no small business set-aside designation, authorizes the delivery of autoinjectors and associated training devices...
This Indefinite Delivery Contract was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, to the prime contractor Pfizer Inc., a large pharmaceutical manufacturer. The contract has a ceiling value of $48,683,160.88 and a period of performance through August 31, 2030. It does not utilize any small business set-asides. The contract primarily aims to procure a wide range of pharmaceutical products and medical supplies for the Department of...
The U.S. Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Pfizer Inc. to supply a wide range of pharmaceutical products, including prescription medications, vaccines, and other critical medical supplies to support various government healthcare initiatives. The $10 million IDC has an ultimate completion date of December 18, 2024 and was originally procured through a competitive solicitation that sought proposals to establish multiple...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $9,999,999.00, runs through December 31, 2025 and serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
The Department of Defense (DoD) Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The 11-year contract (base period plus options) will serve as a prime vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
Pfizer Inc. was awarded a multiple-award Federal Supply Schedule contract for $7.31 billion by the Department of Veterans Affairs' Veterans Integrated Service Network 12 on July 1, 2024, with a completion date of June 30, 2029. This contract, established under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), encompasses drugs, pharmaceuticals, and hematology-related products intended to support the Veterans Health Administration's medical supply requirements. The contract was...
This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $999,999,999 single-award contract runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The...
This single-award Indefinite Delivery Contract, valued at $9.55 million with an ultimate completion date of August 25, 2027, was awarded by the Defense Logistics Agency's Medical Supply Chain division to Mylan Pharmaceuticals Inc. on August 26, 2022. The contract encompasses the manufacture and distribution of pharmaceutical products classified under the Federal Supply Classification code 4610093699. As the prime contractor, Mylan Pharmaceuticals Inc. (UEI: NDN1MYB8DKK5), a registered for-profit...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award IDC, valued at up to $499,999.00, runs through December 24, 2024 and covers the delivery of a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract encompasses critical medical commodities including specialty medications,...
This indefinite delivery contract, awarded by the Defense Logistics Agency Troop Support Medical, provides for the delivery of various medical products and treatments to the U.S. government. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc.
The contract, valued at up to $597 million, has a period of performance from January 1, 2013 to December 31, 2014. It does not utilize any set-aside designations. Meridian has been awarded multiple delivery orders under this contract for items such as pralidoxime chloride, diazepam injection, morphine sulfate, and other nerve agent antidote treatments. The delivery orders are firm-fixed-price, typically ranging from several hundred thousand to over $11 million. The place of performance for these orders is Columbia, Maryland. Pfizer, as Meridian's parent company, is a major supplier of pharmaceuticals and vaccines to various federal agencies to support medical readiness, veteran care, and public health initiatives.